PMC:7784786 / 128-331 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"24","span":{"begin":161,"end":164},"obj":"Gene"},{"id":"29","span":{"begin":155,"end":160},"obj":"Species"},{"id":"33","span":{"begin":103,"end":113},"obj":"Chemical"}],"attributes":[{"id":"A24","pred":"tao:has_database_id","subj":"24","obj":"Gene:923"},{"id":"A29","pred":"tao:has_database_id","subj":"29","obj":"Tax:9606"},{"id":"A33","pred":"tao:has_database_id","subj":"33","obj":"MESH:C000597346"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"OVID-19, the inflammatory cytokine-release syndrome is associated with the progression of the disease. Itolizumab is a monoclonal antibody that recognizes human CD6 expressed in activated T cells. The an"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T2","span":{"begin":26,"end":51},"obj":"Phenotype"}],"attributes":[{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0033041"}],"text":"OVID-19, the inflammatory cytokine-release syndrome is associated with the progression of the disease. Itolizumab is a monoclonal antibody that recognizes human CD6 expressed in activated T cells. The an"}

{"project":"LitCovid-sentences","denotations":[{"id":"T4","span":{"begin":103,"end":196},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"OVID-19, the inflammatory cytokine-release syndrome is associated with the progression of the disease. Itolizumab is a monoclonal antibody that recognizes human CD6 expressed in activated T cells. The an"}